Fangfei Li
- Oncology top 5%
- Molecular Biology
- Organic Chemistry top 10%
- Neurology top 10%
- Pulmonary and Respiratory Medicine
- Topics
- Parkinson's Disease Mechanisms and Treatments (6 papers)Neurological disorders and treatments (4 papers)Immune Cell Function and Interaction (4 papers)
- Cited by
- OncologyNeurologyOrganic Chemistry
- Partner nations
- ChinaHong KongUnited Kingdom
In The Last Decade
Fangfei Li
38 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Oncology 477
- Molecular Biology 440
- Organic Chemistry 265
- Neurology 158
- Pulmonary and Respiratory Medicine 157
Countries citing papers authored by Fangfei Li
This map shows the geographic impact of Fangfei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangfei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangfei Li more than expected).
Fields of papers citing papers by Fangfei Li
This network shows the impact of papers produced by Fangfei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangfei Li. The network helps show where Fangfei Li may publish in the future.
Co-authorship network of co-authors of Fangfei Li
This figure shows the co-authorship network connecting the top 25 collaborators of Fangfei Li. A scholar is included among the top collaborators of Fangfei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangfei Li. Fangfei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 7 | |
| 7 | 1 | |
| 8 | 4 | |
| 9 | Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradationbreakdown → | 113 |
| 10 | 12 | |
| 11 | 6 | |
| 12 | 13 | |
| 13 | 24 | |
| 14 | 12 | |
| 15 | 29 | |
| 16 | 36 | |
| 17 | 4 | |
| 18 | 19 | |
| 19 | 17 | |
| 20 | 1 |
About Fangfei Li
Fangfei Li is a scholar working on Oncology, Rheumatology and Neurology, having authored 41 papers that have together received 1.3k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (6 papers), Neurological disorders and treatments (4 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Oncology (477 citations), Neurology (158 citations) and Organic Chemistry (265 citations). Fangfei Li has collaborated with scholars based in China, Hong Kong and United Kingdom. Frequent co-authors include J. Grant Collins, F. Richard Keene, Ge Zhang, Aiping Lü, Tao Feng, Shun Yu, Xuemei Wang, Xiaoqiu Wu, Chao Liang and Yongshu Li. Their work appears in journals such as Chemical Society Reviews, Nature Communications and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.